ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of ...

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...

ICMR and Panacea Biotec conduct third phase trials for indigenous dengue vaccine in India with promising results.

Global Clinical Trials Review, 2025" offers a comprehensive overview of kidney disease trials worldwide, detailing trial numbers, phases, and status across G7 & E7 countries. This report aids ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended key ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 ...

Evestia Clinical ( formerly known as EMAS Pharma) has merged with Atlantic Research Group (ARG), a US-based CRO, to create an ...

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for ...

Broadens global development program for verekitug into third indication, strengthening pipeline across severe respiratory diseases including chronic rhinosinusitis with nasal polyps (CRSwNP), severe ...

BURLINGTON – Lahey Hospital & Medical Center (LHMC) marked a major milestone with the official opening of its new Clinical ...

Chandigarh: The PGI is at the forefront of India's efforts to develop indigenous solid tumour cancer drugs, serving as one of the four pivotal Phase 1.